Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,445,420
+$107,205 QoQ
Shares Held
5,744
-6.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,210
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GRANDFIELD & DODD, LLC holds $118,444,709 across 12 Drug Manufacturers - General names. ABBV ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
106,768 | $27,115,868 | |
| 2 | NVS |
Novartis AG
|
153,436 | $24,046,489 | |
| 3 | MRK |
Merck & Co., Inc.
|
171,554 | $22,044,689 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
154,287 | $19,492,619 | |
| 5 | SNY |
Sanofi
|
384,643 | $16,408,870 | |
| 6 | AMGN |
Amgen Inc
|
7,491 | $2,712,640 | |
| 7 | LLY |
ELI LILLY & Co
|
2,035 | $2,440,840 | |
| 8 | ABBV |
AbbVie Inc.
This page
|
5,744 | $1,445,420 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,445,420 | 5,744 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,338,215 | 6,153 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,276,345 | 5,586 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,321,398 | 5,707 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,059,333 | 5,707 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,159,064 | 5,532 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $983,036 | 5,532 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,092,459 | 5,532 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,000,304 | 5,832 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,064,556 | 5,846 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $913,548 | 5,895 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $878,708 | 5,895 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $796,523 | 5,912 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $942,195 | 5,912 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $955,438 | 5,912 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $793,852 | 5,915 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $905,941 | 5,915 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $958,880 | 5,915 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $690,133 | 5,097 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $602,238 | 5,583 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $595,077 | 5,283 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $595,426 | 5,502 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $589,539 | 5,502 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $487,175 | 5,562 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $546,077 | 5,562 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $402,816 | 5,287 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||